{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T10:08:31Z","timestamp":1782036511673,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008628","name":"Institut for Klinisk Medicin, Aarhus Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008628","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jhep.2020.07.028","type":"journal-article","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T22:19:26Z","timestamp":1595629166000},"page":"58-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Obeticholic acid improves hepatic bile acid excretion in patients with primary biliary cholangitis"],"prefix":"10.1016","volume":"74","author":[{"given":"Kristoffer","family":"Kj\u00e6rgaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Frisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7232-5088","authenticated-orcid":false,"given":"Ole Lajord","family":"Munk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan Frederick","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Horsager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Christina","family":"Schacht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6514-6073","authenticated-orcid":false,"given":"Mary","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7555-9971","authenticated-orcid":false,"given":"Susanne","family":"Keiding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2020.07.028_bib1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.07.028_bib2","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","article-title":"Primary biliary cirrhosis","volume":"386","author":"Gatselis","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2020.07.028_bib3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0016-5085(94)94899-2","article-title":"Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid","volume":"106","author":"Jazrawi","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.07.028_bib4","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2014.08.029","article-title":"Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study","volume":"147","author":"Lammers","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.07.028_bib5","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.cgh.2019.08.013","article-title":"Factors associated with progression and outcomes of early-stage\u00a0primary biliary cholangitis","volume":"18","author":"Gatselis","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.07.028_bib6","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/0016-5085(89)91698-3","article-title":"Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial","volume":"97","author":"Leuschner","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.07.028_bib7","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","article-title":"Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis","volume":"48","author":"Corpechot","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.07.028_bib8","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","article-title":"Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid","volume":"144","author":"Carbone","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.07.028_bib9","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A\u00a0placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2020.07.028_bib10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/j.gastro.2014.12.005","article-title":"Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid","volume":"148","author":"Hirschfield","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.07.028_bib11","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/hep.29569","article-title":"A\u00a0randomized trial of obeticholic acid monotherapy in\u00a0patients with primary biliary cholangitis","volume":"67","author":"Kowdley","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.07.028_bib12","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond","volume":"62","author":"Beuers","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.07.028_bib13","doi-asserted-by":"crossref","first-page":"e005","DOI":"10.1621\/nrs.08005","article-title":"Deciphering the nuclear bile acid receptor FXR paradigm","volume":"8","author":"Modica","year":"2010","journal-title":"Nucl Recept Signal"},{"key":"10.1016\/j.jhep.2020.07.028_bib14","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1021\/jm025529g","article-title":"6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity","volume":"45","author":"Pellicciari","year":"2002","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.jhep.2020.07.028_bib15","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1021\/jm0582221","article-title":"Farnesoid X receptor: from structure to potential clinical applications","volume":"48","author":"Pellicciari","year":"2005","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.jhep.2020.07.028_bib16","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jhep.2020.07.028_bib17","doi-asserted-by":"crossref","first-page":"8856","DOI":"10.1074\/jbc.M306422200","article-title":"The farnesoid X receptor controls gene expression in a ligand- and promoter-selective fashion","volume":"279","author":"Lew","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhep.2020.07.028_bib18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/bdd.2011","article-title":"Biliary excretion of pravastatin and taurocholate in rats with bile salt export pump (BSEP) impairment","volume":"37","author":"Cheng","year":"2016","journal-title":"Biopharm Drug Disp"},{"key":"10.1016\/j.jhep.2020.07.028_bib19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/03602530903492004","article-title":"Role of the bile salt export pump, BSEP, in acquired forms of cholestasis","volume":"42","author":"Stieger","year":"2010","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.jhep.2020.07.028_bib20","first-page":"73","article-title":"Quantitative PET of liver functions","volume":"8","author":"Keiding","year":"2018","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jhep.2020.07.028_bib21","doi-asserted-by":"crossref","first-page":"772","DOI":"10.2967\/jnumed.111.098731","article-title":"[N-methyl-11C]Cholylsarcosine, a novel bile acid tracer for PET\/CT of hepatic excretory function: radiosynthesis and proof-of-concept studies in pigs","volume":"53","author":"Frisch","year":"2012","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jhep.2020.07.028_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.nucmedbio.2019.07.006","article-title":"Human biodistribution, dosimetry, radiosynthesis and quality control of the bile acid PET tracer [N-methyl-11C]cholylsarcosine","volume":"72\u201373","author":"Frisch","year":"2019","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.jhep.2020.07.028_bib23","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2967\/jnumed.115.171579","article-title":"Hepatobiliary secretion kinetics of conjugated bile acids measured in pigs by 11C-cholylsarcosine PET","volume":"57","author":"S\u00f8rensen","year":"2016","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jhep.2020.07.028_bib24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jhep.2017.02.023","article-title":"Hepatobiliary transport kinetics of the conjugated bile acid tracer 11C-CSar quantified in healthy humans and patients by positron emission tomography (PET)","volume":"67","author":"\u00d8rntoft","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.07.028_bib25","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.bbadis.2017.11.016","article-title":"Functional assessment of hepatobiliary secretion by 11C-cholylsarcosine positron emission tomography","volume":"1864","author":"\u00d8rntoft","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.jhep.2020.07.028_bib26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0016-5085(90)91306-Q","article-title":"Transport, metabolism, and effect of chronic feeding of cholylsarcosine, a conjugated bile acid resistant to deconjugation and dihydroxylation","volume":"98","author":"Schmassmann","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.07.028_bib27","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1172\/JCI115601","article-title":"Physicochemical and physiological properties of cholylsarcosine. A potential replacement detergent for bile acid deficiency states in the small intestine","volume":"89","author":"Lillienau","year":"1992","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2020.07.028_bib28","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/0016-5085(93)90289-O","article-title":"Cholylsarcosine, a new bile acid analogue: metabolism and effect on biliary secretion in humans","volume":"104","author":"Schmassmann","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.07.028_bib29","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1023\/A:1018868126743","article-title":"Adjuvant cholylsarcosine during ursodeoxycholic acid treatment of primary biliary cirrhosis","volume":"43","author":"Ricci","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2020.07.028_bib30","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/hep.29251","article-title":"Hepatic uptake of conjugated bile acids is mediated by both sodium taurocholate cotransporting polypeptide and organic anion transporting polypeptides and modulated by intestinal sensing of plasma bile acid levels in mice","volume":"66","author":"Slijepcevic","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.07.028_bib31","doi-asserted-by":"crossref","first-page":"G671","DOI":"10.1152\/ajpgi.00054.2003","article-title":"Impulse-response function of splanchnic circulation with model-independent constraints: theory and experimental validation","volume":"285","author":"Munk","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2020.07.028_bib32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00259-010-1620-0","article-title":"Tracer input for kinetic modelling of liver physiology determined without sampling portal venous blood in pigs","volume":"38","author":"Winterdahl","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jhep.2020.07.028_bib33","first-page":"795","article-title":"Liver kinetics of glucose analogs measured in pigs by PET: importance of dual-input blood sampling","volume":"42","author":"Munk","year":"2001","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jhep.2020.07.028_bib34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0676.1987.tb00336.x","article-title":"Methodological problems in the use of indocyanine green to estimate hepatic blood flow and ICG clearance in man","volume":"7","author":"Skak","year":"1987","journal-title":"Liver"},{"key":"10.1016\/j.jhep.2020.07.028_bib35","first-page":"G1108","article-title":"Hepatic removal of two fractions of indocyanine after bolus injection in anesthetized pigs","volume":"266","author":"Ott","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jhep.2020.07.028_bib36","first-page":"439","article-title":"The physiologic basis of clearance measurements in hepatology","volume":"14","author":"Winkler","year":"1979","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.07.028_bib37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/00365517609055235","article-title":"Hepatic elimination kinetics: the influence of hepatic blood flow on clearance determinations","volume":"36","author":"Keiding","year":"1986","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.jhep.2020.07.028_bib38","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jhep.2016.01.016","article-title":"Gene expression profiling in human precision cut liver slices in response to the FXR agonist obeticholic acid","volume":"64","author":"Ijssennagger","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.07.028_bib39","doi-asserted-by":"crossref","first-page":"e00329","DOI":"10.1002\/prp2.329","article-title":"Obeticholic acid, a selective farnesoid X receptor agonist, regulates bile acid homeostasis in sandwich-cultured human hepatocytes","volume":"5","author":"Zhang","year":"2017","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.jhep.2020.07.028_bib40","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0168-8278(03)00096-5","article-title":"Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis","volume":"38","author":"Zollner","year":"2003","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.07.028_bib41","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0168-8278(03)00410-0","article-title":"Changes in the expression and localization of hepatocellular transporters\u00a0and radixin in primary biliary cirrhosis","volume":"39","author":"Kojima","year":"2003","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.07.028_bib42","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/cts.12421","article-title":"Modeling and experimental studies of obeticholic acid exposure and the impact of cirrhosis stage","volume":"9","author":"Edwards","year":"2016","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jhep.2020.07.028_bib43","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jhep.2014.08.024","article-title":"Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension","volume":"62","author":"Mookerjee","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.07.028_bib44","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jhep.2016.12.005","article-title":"The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction","volume":"66","author":"Schwabl","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.07.028_bib45","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/jpet.117.246033","article-title":"Farnesoid X\u00a0receptor agonists obeticholic acid and chenodeoxycholic acid increase\u00a0bile acid efflux in sandwich-cultured human hepatocytes: functional evidence and mechanisms","volume":"365","author":"Guo","year":"2018","journal-title":"J\u00a0Pharmacol Exp Ther"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820304815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820304815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:40:53Z","timestamp":1759174853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827820304815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0168827820304815"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2020.07.028","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obeticholic acid improves hepatic bile acid excretion in patients with primary biliary cholangitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2020.07.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Association for the Study of the Liver. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}